Clinical Trial Evaluating Delivery of Regular Human Insulin vs. Rapid Acting Insulin Delivered by Valeritas’ V-Go® Meets Primary A1c Endpoint August 15, 2019 - NASDAQ Companies 0 » View More News for August 15, 2019